Our team PanOncology Trials have been partners of BeiGene since 2018 providing access to therapies including immunotherapy with #antiPDL-1 therapy Tislelizumab for advanced gastric cancer, #Lymphoma and #colorectalcancer

Very grateful to Dr. Dan Welch for the opportunity to lecture @KUCC as part of cancer biology seminar series!! Thank you for the hospitality! I even had the opportunity to visit their Proton Therapy Center with Radiation Oncology Chair Dr. Ron Chen and met brilliant dedicated

Inmediate action AAMC to enter in effect nationwide 👏👏👏👏 aamc.org/news/press-rel…

Thank you Dr. Foti for your leadership as a woman scientist and leader Margaret Foti, PhD, MD (hc) AACR

Participating gastropr 5th Caribbean Congress on Therapeutic Congress! An extraordinary meeting with faculties from Columbia University Dr. Amrita Sethi, Jackson Memorial,Mount Sinai Health System Johns Hopkins Medicine PanOncology Trials Congratulations to Dr. Kermit Richiez, President of APG, Dr.

Celebrating the life of Hector Luis “Tito” Cruz, my father who turned 80 years old and has the energy and health of a young man! Congratulations Papi from all your daughters, siblins, nieces/nephews, grandchildren and great grandson Atlas😍 May your life be full of health &

A refreshing wise perspective for cancer prevention, early detection and treatment within oncology community clinical trials (PanOncology Trials Sarah Cannon Docs Parker Institute AstraZeneca) implementing and expanding USA executive policies and programs, kudos! The War on Cancer

Congratulations to Dr. Karen Knudsen for her new stage as a CEO of Parker Institute for Cancer Immunology👏👏👏 An extraordinary scientist, leader and pioneer to join #PICI to translate research into discoveries that impact health🧡💪 #clinicaltrials #cancerdiscoveries

Extraordinary news for our patients with MSI-high #colorectalcancer Including patients with Lynch Sundrome and close to 10% of sporadic colon cancer. Our team collaborated in the clinical trials that evaluated the combination therapy and the patient who was ss the 1st patient in

Our team had the opportunity to participate ⁦Jugando Pelota Dura🇵🇷⁩ to talk about #ClinicalTrials for oncology. PanOncology continues to bring to 🇵🇷 innovative options to improve outcomes 🙏 #clinicaltrials #Health #Innovations #oncology #immunotherapy teleonce.com/programas/unca…

Advanced colorectal cancer continues to be among the most common and deadliest. Tumors with microsatellite instability now received FDA approval with Opdivo/Yervoy, offers great overall survival compared to SOC as 1st line therapy. ⁦PanOncology Trials⁩ primerahora.com/suplementos/pu…

Extraordinary participation of the Centro Comprensivo de Cancer UPR duting #AACR25 in Chicago. Congratulations to all and special recognition to all scientists who received traveling awards👏👏👏 Thank you AACR Margaret Foti, PhD, MD (hc) National Cancer Institute for supporting the science that transform lives 🇵🇷 Financial Oversight & Mgmt Board for Puerto Rico

In a robust article published AACR Cancer Discoveries increasing cancer incidence for people <50 years between 2010 to 2019 was found for female breast, colorectal, kidney and uterine cancers. Multiple factors including obesity, diet and environment exposures might contribute to

Mission accomplished🙌 Our ⁦PanOncology Trials⁩ Team participated #ASCO25 presenting scientific posters and meeting with many colleagues and extraordinary scientists ⁦BeOne Medicines⁩ ⁦Pfizer Inc.⁩ ⁦Astellas Pharma US⁩ ⁦Incyte⁩ ⁦AbbVie⁩ ⁦FDA Oncology⁩

Paradigm shifting results from the RCT for Gastric Cancer patients using IO and FLOT demonstrating benefits in DFS with the integration of IO to FLOT backbone chemo 💪🙌 MATTERHORN: Durvalumab + Chemotherapy Demonstrates Superior EFS Over Standard of Care in Resectable

So proud of my cousin Karina Alvarado who was elected as part of the to finalist Miss Universe It is extraordinary to see you shine and continue to pursue your dreams❤️🥳🥳🥳 Ad a nutritionist you have demonstrated the importance of dietary habits in promoting health and

Participating @ESMO Berlin during the annual congress #ESMO25 Our team presented data on ADC Met targeting agent for Stage IV Colorectal and pancreas cancer with increase ORR. Several other Bispecific antibodies are demonstrating promising results for #Pancreascancer

Expedited FDA pilot project to shorten the drug approval process has included the KRAS inhibitor from Revilution Medicine (RMC-636) for Pancreas Cancer. Our team PanOncology Trials across Puerto Rico 🇵🇷 have been actively involved in the evaluation of RMC-6236 for multiple indications